Oncolytics Biotech Inc. Stock News

Oncolytics Biotech (NASDAQ:ONCY) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a report released on Friday, ValuEngine reports. A number of other equities analysts also

SAN DIEGO and CALGARY, Alberta , April 30, 2020 /CNW/ -- Oncolytics Biotech ® Inc. (ONCY) (ONC.TO), (the "Company") today announced that in light of the ongoing COVID-19 pandemic, it is taking

Oncolytics Biotech, Inc. (NASDAQ:ONCY) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 1,260,000 shares, a de

SAN DIEGO, California and CALGARY, Alberta , April 17, 2020 /CNW/ -- Oncolytics Biotech® Inc. (ONCY) (ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus,

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...

Oncolytics Biotech® Announces Publication of Pelareorep's Clinical Benefit Against KRAS Mutated Colorectal Cancer

In a report released today, Kenneth Herbert from Canaccord Genuity maintained a Buy rating on Oncolytics Biotech (ONCY), with a price target of $25.00.

In a report released today, Kenneth Herbert from Canaccord Genuity maintained a Buy rating on Oncolytics Biotech ( ONCY – Research Report ), with a price target of $25.00 . The company’s shares cl

Novavax (NASDAQ:NVAX) +40% on successful NanoFlu study.ThermoGenesis Holdings (NASDAQ:THMO) +32% on FY results.Century Casinos (NASDAQ:CNTY) +29%.Oncolytics Biotech (NASDAQ:ONCY) +27% on favourable

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced a favourable assessment from the Safety Committ